Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Start Codon Fund 1 L.P. (Acting By Its General Partner, Start Codon General Partner Ltd) investment portfolio

Start Codon Fund 1 L.P. (Acting By Its General Partner, Start Codon General Partner Ltd) has made numerous investments in companies such as Semarion, Trimtech Therapeutics, and Zygosity within the Biotech sector.

vc
Portfolio
7
Team
0

Portfolio (7)

CompanySectorCitySourceLast confirmed on
Coding Bio Limited
Coding Bio develops modular immunotherapies—such as CAR and BiTE proteins—by combining high‑throughput cellular screening with machine‑learning design to rapidly identify and produce cancer‑targeting treatments. Its services are aimed at biotech and pharmaceutical partners seeking faster, data‑driven development of cancer immunotherapies.
Healthcare & Life SciencesOxfordConfirmed2025-11-24
Erebagen Ltd
Erebagen Ltd is a biotechnology company that develops natural biocatalysts to transform chemical manufacturing processes, targeting the chemical and life‑science sectors.
Healthcare & Life SciencesKidlingtonConfirmed2026-03-29

Sign up to see the full portfolio

+5 more companies

Sign up

Shareholding changes (7)

Start Codon Fund 1 L.P. (Acting By Its General Partner, Start Codon General Partner Ltd)'s positions across portfolio companies
2026
  • 04-01ConvertedStembond Technologies Ltd
    • A1 ORDINARY. 371,795 → 0
    • ORDINARY 95,238 → 0
    • A1 ORDINARY. 0.000001 GBP 0 → 371,795
    • ORDINARY 0.000001 GBP 0 → 95,238
2025

Sign up free to see when this investor has bought or sold shares.

+5 more changes

Sign up

Articles (1)